Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer. (Q45966817)

18 December 2017

title

Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer. (English)

1 reference

18 December 2017

author name string

Thomas C Harding

1

1 reference

18 December 2017

Li Long

2

1 reference

18 December 2017

Servando Palencia

3

1 reference

18 December 2017

Hongbing Zhang

4

1 reference

18 December 2017

Ali Sadra

5

1 reference

18 December 2017

Kevin Hestir

6

1 reference

18 December 2017

Namrata Patil

7

1 reference

18 December 2017

Anita Levin

8

1 reference

18 December 2017

Amy W Hsu

9

1 reference

18 December 2017

Deborah Charych

10

1 reference

18 December 2017

Thomas Brennan

11

1 reference

18 December 2017

James Zanghi

12

1 reference

18 December 2017

Robert Halenbeck

13

1 reference

18 December 2017

Shannon A Marshall

14

1 reference

18 December 2017

Minmin Qin

15

1 reference

18 December 2017

Stephen K Doberstein

16

1 reference

18 December 2017

Diane Hollenbaugh

17

1 reference

18 December 2017

W Michael Kavanaugh

18

1 reference

18 December 2017

Lewis T Williams

19

1 reference

18 December 2017

Kevin P Baker

20

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 March 2013

1 reference

18 December 2017

Science Translational Medicine

published in

1 reference

18 December 2017

volume

5

1 reference

18 December 2017

issue

178

1 reference

18 December 2017

page(s)

178ra39

1 reference

18 December 2017

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Liver-specific activities of FGF19 require Klotho beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Synergistic induction of mesoderm by FGF and TGF-beta and the identification of an mRNA coding for FGF in the early Xenopus embryo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Basic fibroblast growth factor induces angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

The function of KGF in morphogenesis of epithelium and reepithelialization of wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Fibroblast growth factor signalling: from development to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Drug-sensitive FGFR2 mutations in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

FGFs, their receptors, and human limb malformations: clinical and molecular correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Cartilage dysplasia and tissue mineralization in the rat following administration of a FGF receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Structural and Functional Diversity in the FGf Receptor Multigene Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Amplification of chromosomal segment 4q12 in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

A therapeutic target for smoking-associated lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

High-level expression of proteins in mammalian cells using transcription regulatory sequences from the Chinese hamster EF-1alpha gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3005414

10.1126/SCITRANSLMED.3005414

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

23536011

1 reference

18 December 2017